相关实验视频
Updated: Jul 28, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
493
RPS15与IGF2BP1相互作用,通过识别m6A修饰促进食道状细胞癌的发展
Yahui Zhao1, Yang Li1, Rui Zhu1
1State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Signal transduction and targeted therapy
|June 1, 2023
概括
核糖体蛋白15 (RPS15) 通过促进细胞转移和增殖,驱动食道癌的进展. 用叶酸和西斯普拉丁向RPS15显示了对食道状细胞癌 (ESCC) 的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 升高的核糖体生物生成是各种癌症的标志,与患者预后不佳有关.
- 核糖体蛋白 (RPs) 在癌症的发展和进展中起着关键作用.
研究的目的:
- 在食道状细胞癌 (ESCC) 中识别瘤性核糖体蛋白.
- 研究RPS15在ESCC中的功能作用和分子机制.
- 探索针对RPS15.5的潜在治疗策略.
主要方法:
- 在ESCC中对89个RP进行CRISPR协同激活介质 (SAM) 系统选.
- 在体外和体内的功能模型的收益和损失.
- 涉及蛋白质-蛋白质相互作用和mRNA结合的机制研究.
- 有针对性的药物虚拟查和功能测试.
主要成果:
- 高RPS15表达与恶性表型和ESCC的不良预后相关.
- RPS15促进ESCC细胞转移和增殖.
- RPS15与IGF2BP1相互作用,以增强p38 MAPK通路蛋白转化.
- 叶酸通过向RPS15,增强了cisplatin,证明了对ESCC的治疗效果.
结论:
- RPS15通过p38 MAPK信号通路驱动ESCC的进展.
- 通过叶酸,IGF2BP1剥离或SB203580抑制RPS15,可以抑制ESCC.
- RPS15抑制剂代表食道状细胞癌的潜在治疗剂.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K

